Two Sigma Investments, LP Travere Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 768,794 shares of TVTX stock, worth $13.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

768,794

Previous 693,016 10.93%

Holding current value

$13.4 Million

Previous $12.1 Million 14.12%

% of portfolio

0.03%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$17.07 - $23.75 $1.29 Million - $1.8 Million	75,778 Added 10.93%	768,794 $13.8 Million
Q4 2024 Feb 14, 2025	BUY	$13.65 - $19.85 $4.54 Million - $6.61 Million	332,933 Added 92.46%	693,016 $12.1 Million
Q3 2024 Nov 14, 2024	BUY	$7.89 - $15.21 $362,174 - $698,184	45,903 Added 14.61%	360,083 $5.04 Million
Q2 2024 Aug 14, 2024	SELL	$5.26 - $8.28 $1.19 Million - $1.87 Million	-225,904 Reduced 41.83%	314,180 $2.58 Million
Q1 2024 May 15, 2024	BUY	$7.18 - $9.82 $1.23 Million - $1.68 Million	171,415 Added 46.5%	540,084 $4.16 Million
Q4 2023 Feb 14, 2024	BUY	$5.44 - $9.5 $2.01 Million - $3.5 Million	368,669 New	368,669 $3.31 Million
Q2 2023 Aug 14, 2023	SELL	$15.3 - $22.61 $1.72 Million - $2.54 Million	-112,446 Reduced 20.31%	441,267 $6.78 Million
Q1 2023 May 15, 2023	BUY	$17.82 - $22.89 $6.3 Million - $8.1 Million	353,702 Added 176.84%	553,713 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$18.47 - $26.14 $1.68 Million - $2.37 Million	90,845 Added 83.22%	200,011 $4.21 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $2.09 Million - $2.61 Million	-91,167 Reduced 45.51%	109,166 $2.69 Million
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $340,358 - $487,782	-16,254 Reduced 7.5%	200,333 $4.85 Million
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $2.81 Million - $3.65 Million	119,187 Added 122.37%	216,587 $5.58 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $2.37 Million - $3.04 Million	97,400 New	97,400 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $473,390 - $885,720	-33,550 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $142,253 - $193,383	-6,087 Reduced 15.36%	33,550 $838,000
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $759,841 - $1.1 Million	39,637 New	39,637 $1.08 Million

Others Institutions Holding TVTX

# of Institutions

242

Shares Held

102M

Call Options Held

1.79M

Put Options Held

540K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Travere Therapeutics, Inc. Transaction History